JP2016502980A5 - - Google Patents

Download PDF

Info

Publication number
JP2016502980A5
JP2016502980A5 JP2015546771A JP2015546771A JP2016502980A5 JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5 JP 2015546771 A JP2015546771 A JP 2015546771A JP 2015546771 A JP2015546771 A JP 2015546771A JP 2016502980 A5 JP2016502980 A5 JP 2016502980A5
Authority
JP
Japan
Prior art keywords
agent according
respiratory disease
cells
stro
asthma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015546771A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016502980A (ja
JP6313327B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2013/001454 external-priority patent/WO2014089625A1/en
Publication of JP2016502980A publication Critical patent/JP2016502980A/ja
Publication of JP2016502980A5 publication Critical patent/JP2016502980A5/ja
Application granted granted Critical
Publication of JP6313327B2 publication Critical patent/JP6313327B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015546771A 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法 Active JP6313327B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261736352P 2012-12-12 2012-12-12
US61/736,352 2012-12-12
PCT/AU2013/001454 WO2014089625A1 (en) 2012-12-12 2013-12-12 Methods of treating or preventing respiratory conditions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018055386A Division JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法

Publications (3)

Publication Number Publication Date
JP2016502980A JP2016502980A (ja) 2016-02-01
JP2016502980A5 true JP2016502980A5 (enExample) 2017-02-02
JP6313327B2 JP6313327B2 (ja) 2018-04-18

Family

ID=50933587

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2015546771A Active JP6313327B2 (ja) 2012-12-12 2013-12-12 呼吸器系疾患を治療又は予防する方法
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2018055386A Active JP6665218B2 (ja) 2012-12-12 2018-03-22 呼吸器系疾患を治療又は予防する方法
JP2020026138A Pending JP2020097618A (ja) 2012-12-12 2020-02-19 呼吸器系疾患を治療又は予防する方法
JP2022024306A Active JP7420844B2 (ja) 2012-12-12 2022-02-18 呼吸器系疾患を治療又は予防する方法
JP2024002878A Pending JP2024041904A (ja) 2012-12-12 2024-01-11 呼吸器系疾患を治療又は予防する方法

Country Status (11)

Country Link
US (3) US10028979B2 (enExample)
EP (1) EP2931373B1 (enExample)
JP (5) JP6313327B2 (enExample)
KR (1) KR101748712B1 (enExample)
CN (2) CN105377274A (enExample)
AU (4) AU2013360026B2 (enExample)
CA (1) CA2893951C (enExample)
ES (1) ES2759281T3 (enExample)
IL (1) IL239309A0 (enExample)
SG (2) SG11201504352TA (enExample)
WO (1) WO2014089625A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions
US20170296589A1 (en) * 2014-09-23 2017-10-19 Case Western Reserve University Compositions and methods for treating lung remodeling diseases
KR20200053501A (ko) * 2017-09-15 2020-05-18 시나타 세라퓨틱스 엘티디 알레르기성 기도 질환 (aad)/ 천식을 치료하는 방법
EP4098267A4 (en) * 2020-01-30 2024-03-06 JCR Pharmaceuticals Co., Ltd. MEDICINAL COMPOSITION COMPRISING CELLS DERIVED FROM DENTAL PULP
JP7551341B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
JP7551340B2 (ja) * 2020-06-04 2024-09-17 株式会社三共 遊技機
CN118800458B (zh) * 2024-09-14 2024-11-15 吉林大学 一种心胸外科术后并发症预测方法及系统

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003901668A0 (en) * 2003-03-28 2003-05-01 Medvet Science Pty. Ltd. Non-haemopoietic precursor cells
ES2287447T3 (es) * 2002-02-19 2007-12-16 Medipost, Co., Ltd. Metodos de aislamiento y expansion del cultivo de celulas troncales/madre mesenquimatosas a partir de sangre del cordon umbilical, y metodo de diferenciacion de celulas troncales/madre mesenquimatosas derivadas de sangre del cordon umbilical en diversos tejidos mesenquimatosos.
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
CN101506355B (zh) 2004-09-24 2012-06-27 成血管细胞系统公司 多能扩增间充质前体细胞子代(memp)及其应用
CN101248171B (zh) 2005-04-12 2015-11-25 迈索布拉斯特股份有限公司 通过组织非特异性碱性磷酸酶分离成人多潜能细胞
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
US20090053182A1 (en) * 2007-05-25 2009-02-26 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
US9381216B2 (en) * 2007-08-06 2016-07-05 Mesoblast, Inc. Methods of generating, repairing and/or maintaining connective tissue in vivo
DK2205721T3 (en) * 2007-10-17 2016-10-24 Txcell TR1 cells mesenchymal stem cells and uses thereof
EP2324109B1 (en) * 2008-09-03 2016-10-26 Mesoblast, Inc. Expansion of haemopoietic precursors
KR101891260B1 (ko) * 2010-07-02 2018-08-24 메소블라스트, 아이엔씨. T-세포 매개된 면역 질환의 치료
US9901600B2 (en) * 2011-03-11 2018-02-27 Children's Medical Center Corporation Methods and compositions relating to mesenchymal stem cell exosomes
AU2012262675B2 (en) 2011-06-03 2016-05-19 Mesoblast, Inc Methods of treating or preventing neurological diseases
CA2893951C (en) 2012-12-12 2022-05-03 Mesoblast, Inc. Methods of treating or preventing respiratory conditions

Similar Documents

Publication Publication Date Title
JP2016502980A5 (enExample)
Pappas et al. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma
EA201591269A1 (ru) Способы лечения аутоиммунных, респираторных и воспалительных расстройств ингаляцией n-оксида рофлумиласта
JP2014501518A5 (enExample)
UA100777C2 (ru) Вдыхаемые частички, содержащие тиотропий
RU2015143254A (ru) Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток
EA201190108A1 (ru) Фармацевтическая композиция для ингаляции
EA201000785A1 (ru) Композиции для доставки в легкие
JP2008513467A5 (enExample)
Holland et al. Impact of pulmonary exposure to gold core silver nanoparticles of different size and capping agents on cardiovascular injury
PE20141012A1 (es) Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion
EA201590019A1 (ru) Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы
SG10201807682PA (en) Methods of Treating or Preventing Respiratory Conditions
JP2013507945A5 (enExample)
EP2120935A4 (en) NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA
WO2015049519A3 (en) Method and apparatus for making compositions for pulmonary administration
EA201201393A1 (ru) Ингалятор, разработанный для доставки лекарственного средства в виде сухого порошка
UA115989C2 (uk) Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
JP2016504311A5 (enExample)
van Echteld et al. A view on imaging in drug research and development for respiratory diseases
EP2125728A4 (en) NOVEL COMBINATION OF COMPOUNDS FOR THE TREATMENT OF AIRWAY DISEASES, IN PARTICULAR CHRONIC OBSTRUCTIVE BRONCHOPNEUMOPATHY (COPD) AND ASTHMA
Krimmer et al. Exposure To Biomass Smoke Extract Enhances Fibronectin Release From Human Lung Fibroblasts
Gazzola Allergy immunotherapy tablets prove successful for both grass pollen and dust mites
CN201879100U (zh) 一种桌子
Xiong et al. Lung Mononuclear Phagocytes Require Functional CX3CR1 To Express Inflammatory Cytokines During Cigarette Smoke Exposure